{"id":"hexoprenaline","rwe":[],"tags":[{"label":"hexoprenaline","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"R03AC06","category":"atc"},{"label":"Active","category":"status"},{"label":"Adrenergic Agents","category":"pharmacology"},{"label":"Adrenergic Agonists","category":"pharmacology"},{"label":"Adrenergic beta-2 Receptor Agonists","category":"pharmacology"},{"label":"Adrenergic beta-Agonists","category":"pharmacology"},{"label":"Anti-Asthmatic Agents","category":"pharmacology"},{"label":"Bronchodilator Agents","category":"pharmacology"},{"label":"Neurotransmitter Agents","category":"pharmacology"},{"label":"Peripheral Nervous System Agents","category":"pharmacology"},{"label":"Reproductive Control Agents","category":"pharmacology"},{"label":"Respiratory System Agents","category":"pharmacology"},{"label":"Tocolytic Agents","category":"pharmacology"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"ipradol","offLabel":[],"synonyms":["delaprem","hexoprenaline","ipradol","hexoprenaline hydrochloride","hexoprenaline dihydrochloride","hexoprenaline sulfate","hexoprenaline HCl"],"timeline":[],"approvals":[],"brandName":"Ipradol","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"hexoprenaline","explanation":"Imagine your body's 'fight or flight' response, where your heart beats faster and your blood pressure rises to help you react quickly to a threat. Ipradol triggers this response by binding to special receptors on the surface of cells, which sends a signal to increase heart rate and blood pressure. This can be helpful in certain medical situations, but it can also have negative effects if not used carefully.","oneSentence":"Ipradol works by stimulating beta-adrenergic receptors in the body, which can increase heart rate and blood pressure.","technicalDetail":"Ipradol exerts its effects through non-selective activation of beta-adrenergic receptors, leading to increased sympathetic tone and subsequent increases in heart rate, contractility, and blood pressure."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1372","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=HEXOPRENALINE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T11:53:11.424034","biosimilars":[],"competitors":[{"drugName":"salbutamol","drugSlug":"salbutamol","fdaApproval":"1981-05-01","relationship":"same-class"},{"drugName":"terbutaline","drugSlug":"terbutaline","fdaApproval":"1974-03-25","genericCount":9,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"isoetarine","drugSlug":"isoetarine","fdaApproval":"1979-10-23","relationship":"same-class"},{"drugName":"pirbuterol","drugSlug":"pirbuterol","fdaApproval":"1986-12-30","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"salmeterol","drugSlug":"salmeterol","fdaApproval":"1994-02-04","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"formoterol","drugSlug":"formoterol","fdaApproval":"2001-02-16","genericCount":10,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"clenbuterol","drugSlug":"clenbuterol","fdaApproval":"","relationship":"same-class"},{"drugName":"bitolterol","drugSlug":"bitolterol","fdaApproval":"1984-12-28","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"indacaterol","drugSlug":"indacaterol","fdaApproval":"2011-07-01","patentExpiry":"Oct 11, 2028","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"olodaterol","drugSlug":"olodaterol","fdaApproval":"2014-07-31","patentExpiry":"Jan 19, 2027","patentStatus":"Patent protected","relationship":"same-class"}],"genericName":"hexoprenaline","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"salbutamol","brandName":"salbutamol","genericName":"salbutamol","approvalYear":"1981","relationship":"same-class"},{"drugId":"terbutaline","brandName":"terbutaline","genericName":"terbutaline","approvalYear":"1974","relationship":"same-class"},{"drugId":"isoetarine","brandName":"isoetarine","genericName":"isoetarine","approvalYear":"1979","relationship":"same-class"},{"drugId":"pirbuterol","brandName":"pirbuterol","genericName":"pirbuterol","approvalYear":"1986","relationship":"same-class"},{"drugId":"salmeterol","brandName":"salmeterol","genericName":"salmeterol","approvalYear":"1994","relationship":"same-class"},{"drugId":"formoterol","brandName":"formoterol","genericName":"formoterol","approvalYear":"2001","relationship":"same-class"},{"drugId":"clenbuterol","brandName":"clenbuterol","genericName":"clenbuterol","approvalYear":"","relationship":"same-class"},{"drugId":"bitolterol","brandName":"bitolterol","genericName":"bitolterol","approvalYear":"1984","relationship":"same-class"},{"drugId":"indacaterol","brandName":"indacaterol","genericName":"indacaterol","approvalYear":"2011","relationship":"same-class"},{"drugId":"olodaterol","brandName":"olodaterol","genericName":"olodaterol","approvalYear":"2014","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NUI":"N0000166518","NDDF":"006635","UNII":"G9L6B3W684","CHEBI":"CHEBI:31670","INN_ID":"2650","RXNORM":"258331","UMLSCUI":"C0019476","ChEMBL_ID":"CHEMBL1589896","KEGG_DRUG":"D02396","DRUGBANK_ID":"DB08957","PUBCHEM_CID":"3609","SNOMEDCT_US":"704987001","SECONDARY_CAS_RN":"4323-43-7","MESH_DESCRIPTOR_UI":"D006594"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":154,"therapeuticAreas":["Cardiovascular"],"atcClassification":{"source":"DrugCentral","atcCode":"R03AC06","allCodes":["R03AC06","R03CC05"]},"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ipradol, also known as hexoprenaline, is a small molecule drug in the hexoprenaline class. Its exact target and mechanism of action are unknown, but it is believed to work as a beta-adrenergic agonist. Ipradol's commercial status and approved indications are unclear, and it is not known whether it is patented or available as a generic. Further research is needed to determine its safety profile and potential uses. As a result, Ipradol is not widely recognized or used in clinical practice.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}